Fondaparinux Sodium
25 NDCs across 5 manufacturers|25 Generic,0 Brand
Fondaparinux Sodium is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 7, 2001, and the first generic was approved Jul 11, 2011. In 2024, Medicare Part D spent $15 million on Fondaparinux Sodium across 13,000 claims for 2,726 beneficiaries.
Fondaparinux Sodium is available as 25 NDCs from 5 manufacturers (25 generic, 0 brand), with NADAC prices from $12.26 to $55.31 per ML — the most expensive product costs about 4.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
25
25G / 0B
Manufacturers
5
competing in market
Price Spread
$12.26 – $55.31
per ML
7d Activity
avg +0.8% WoW · of 25 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
5 manufacturers producing FONDAPARINUX SODIUM
Frequently Asked Questions
What is Fondaparinux Sodium used to treat?
Fondaparinux Sodium is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
When did Fondaparinux Sodium become available as a generic?
FDA approved the first generic Fondaparinux Sodium (ANDA) on Jul 11, 2011.
How much does Medicare spend on Fondaparinux Sodium?
In 2024, Medicare Part D spent $15 million on Fondaparinux Sodium across 13,000 claims for 2,726 beneficiaries.
How many Fondaparinux Sodium products are on the market?
The Fondaparinux Sodium drug market contains 25 NDCs from 5 manufacturers — 25 generic and 0 brand products.
What is the price range for Fondaparinux Sodium?
NADAC reference prices for Fondaparinux Sodium range from $12.2558 to $55.3125 per ML — the most expensive product costs about 4.5× the cheapest.
Which manufacturers make Fondaparinux Sodium?
5 manufacturers list Fondaparinux Sodium in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (7), Zydus Pharmaceuticals (USA) Inc. (6), Eugia US LLC (4), Sandoz Inc. (4), Mylan Institutional LLC (4).
How has the price of Fondaparinux Sodium changed recently?
Over the past 7 days, 10 Fondaparinux Sodium NDCs rose and 6 fell, with a market-wide average change of +0.8%.